Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|March 10, 2000
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivitiesF Carlomagno, N G Burnet, I Turesson, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2002
Normal tissue response to low doses of radiotherapy assessed by molecular markers--a study of skin in patients treated for prostate cancerI Turesson, R Bernefors, M Book, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1986
Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of CancerJ C Horiot, K A Johansson, D G Gonzalez, et al.
British Journal of Haematology|October 16, 1999
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factorsI Turesson, N Abildgaard, T Ahlgren, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II StudyG Saeter, T A Alvegård, O R Monge, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaK Cocks, D Cohen, F Wisløff, et al.
Cancer|February 15, 1981
Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study GroupK Kristiansen, S Hagen, T Kollevold, et al.
Bone Marrow Transplantation|May 1, 1996
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML GroupB Simonsson, G Oberg, M Björeman, et al.
Blood Cancer Journal|March 25, 2014
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglinO E Olsen, K F Wader, K Misund, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell supportN Gulbrandsen, F Wisløff, L Brinch, et al.
Pageof 13